P&U/Monsanto Merger Pitch Will Run Through Feb. 16
Executive Summary
The P&U/Monsanto merger road show has cut by half the gap between Novartis' October offer for Monsanto and the current value of the company.
You may also be interested in...
AHP Sale Of Cyanamid To BASF Will Re-Open Merger Possibilities
The sale of American Home Products' agricultural and crop sciences division Cyanamid will give the company a pharmaceutical profile that clears the way for a new round of merger discussions.
AHP Sale Of Cyanamid To BASF Will Re-Open Merger Possibilities
The sale of American Home Products' agricultural and crop sciences division Cyanamid will give the company a pharmaceutical profile that clears the way for a new round of merger discussions.
Genomic R&D Investment Should Track Functional Data - Novartis' Karabelas
Genomics-based research & development programs that do not concentrate on data tied to functional information risk squandering resources, Novartis Worldwide Pharmaceutical Division CEO Argeris Karabelas told the PDA International Congress Feb. 14 in Basel, Switzerland.